Canada
· Delayed Price · Currency is CAD Kits Eyecare Statistics
Total Valuation
Kits Eyecare has a market cap or net worth of CAD 518.19 million. The enterprise value is 510.04 million.
| Market Cap | 518.19M |
| Enterprise Value | 510.04M |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Kits Eyecare has 32.01 million shares outstanding. The number of shares has increased by 7.68% in one year.
| Current Share Class | 32.01M |
| Shares Outstanding | 32.01M |
| Shares Change (YoY) | +7.68% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 22.56% |
| Owned by Institutions (%) | 11.02% |
| Float | 14.29M |
Valuation Ratios
The trailing PE ratio is 117.37 and the forward PE ratio is 75.90.
| PE Ratio | 117.37 |
| Forward PE | 75.90 |
| PS Ratio | 3.03 |
| PB Ratio | 8.51 |
| P/TBV Ratio | 27.83 |
| P/FCF Ratio | 82.84 |
| P/OCF Ratio | 55.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 61.69, with an EV/FCF ratio of 81.54.
| EV / Earnings | 109.57 |
| EV / Sales | 2.98 |
| EV / EBITDA | 61.69 |
| EV / EBIT | 88.90 |
| EV / FCF | 81.54 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.28 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 1.15 |
| Debt / FCF | 1.52 |
| Interest Coverage | 5.28 |
Financial Efficiency
Return on equity (ROE) is 8.21% and return on invested capital (ROIC) is 5.21%.
| Return on Equity (ROE) | 8.21% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 5.21% |
| Return on Capital Employed (ROCE) | 8.64% |
| Revenue Per Employee | 1.06M |
| Profits Per Employee | 28,735 |
| Employee Count | 162 |
| Asset Turnover | 1.77 |
| Inventory Turnover | 5.60 |
Taxes
In the past 12 months, Kits Eyecare has paid 2.02 million in taxes.
| Income Tax | 2.02M |
| Effective Tax Rate | 30.27% |
Stock Price Statistics
The stock price has increased by +79.89% in the last 52 weeks. The beta is 0.33, so Kits Eyecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +79.89% |
| 50-Day Moving Average | 13.25 |
| 200-Day Moving Average | 10.44 |
| Relative Strength Index (RSI) | 78.87 |
| Average Volume (20 Days) | 30,021 |
Short Selling Information
The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 14,456 |
| Short Previous Month | 16,245 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kits Eyecare had revenue of CAD 171.15 million and earned 4.66 million in profits. Earnings per share was 0.14.
| Revenue | 171.15M |
| Gross Profit | 59.59M |
| Operating Income | 5.74M |
| Pretax Income | 6.68M |
| Net Income | 4.66M |
| EBITDA | 7.31M |
| EBIT | 5.74M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 17.68 million in cash and 9.53 million in debt, giving a net cash position of 8.15 million or 0.25 per share.
| Cash & Cash Equivalents | 17.68M |
| Total Debt | 9.53M |
| Net Cash | 8.15M |
| Net Cash Per Share | 0.25 |
| Equity (Book Value) | 60.92M |
| Book Value Per Share | 1.90 |
| Working Capital | 9.81M |
Cash Flow
In the last 12 months, operating cash flow was 9.38 million and capital expenditures -3.13 million, giving a free cash flow of 6.26 million.
| Operating Cash Flow | 9.38M |
| Capital Expenditures | -3.13M |
| Free Cash Flow | 6.26M |
| FCF Per Share | 0.20 |
Margins
Gross margin is 34.81%, with operating and profit margins of 3.35% and 2.72%.
| Gross Margin | 34.81% |
| Operating Margin | 3.35% |
| Pretax Margin | 3.90% |
| Profit Margin | 2.72% |
| EBITDA Margin | 4.27% |
| EBIT Margin | 3.35% |
| FCF Margin | 3.65% |
Dividends & Yields
Kits Eyecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.68% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.90% |
| FCF Yield | 1.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kits Eyecare has an Altman Z-Score of 5.82 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.82 |
| Piotroski F-Score | 8 |